{"ticker": {"uuid": "78134086-d01e-488f-b9bd-1f2f022b49f2", "symbol": "GDRX", "name": "Goodrx Holdings\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Health Information Services"}, "articles": [{"title": "Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/stocks-making-big-moves-yesterday-200711198.html", "source_name": "StockStory", "published_at": "2026-07-14T20:07:11+00:00", "published_display": "14 Jul 2026 20:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPN2NESkluMlFsRTBKM3NUOUN5WkJkMlQ1bE9ieDdWcTJPRnZDWFBVclp4X2ZOWUdSblRwMlFVdXNYRlloSHVqMFFLWHF3RHk2SWJaUndZSEVMdTd4Z2dHa2x1bWFid3p4RFJnNktINXJyVDBHSE9IazEzakFHa1Zud0V4N2pWNnZiMUVHUGI5UlU1dG1DWE1BTw?oc=5", "source_name": "Market source", "published_at": "2026-07-13T23:50:39+00:00", "published_display": "13 Jul 2026 23:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings (GDRX) Pharma Growth Story Meets A Small Fair Value Gap", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPQ3NsZTBqNWExRmVmSWMxcDE3NWRMeThvbTJvQnRSMlBQMjVDOW1nWEluNmFKaW5HOHVxc1RYXzJESG1KaGNfd0dFOXQzaFlaSVpsTXZHQ2lRNVlRcTlJTHZ6eGtKUFRKdWQwd0t4YkpTb3ZINGRic3U0YzktNFBpdk5VQ0R6aTVRQS0tNGxDbzlsUHZvZGc3bU5MdFRuSzJZ?oc=5", "source_name": "Market source", "published_at": "2026-07-12T05:07:00+00:00", "published_display": "12 Jul 2026 05:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) Stock Looks Full On Earnings But Mixed On Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOM2E3NW5vY3hZNXF0bUx6cFBtMlAyN2ZsWHk1bmlhazVzRFM3ZGd2SzRQRXhaZ0JWTXJNb1V5eVU4bWZFdmlZRmNMcjdiRjlRNTVBa1V1MHNTWlVXSThvTGdkMUpXSVlYMUhoS3pmdEdZN3dXd1VSQXV0dHEtWTY3MTdSRlpKamhFcUFMVmpESW5sZ0RzazZUcg?oc=5", "source_name": "Market source", "published_at": "2026-07-11T07:10:18+00:00", "published_display": "11 Jul 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings (GDRX) Sets Q2 Results Date, Is The Stock Still Undervalued?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T02:31:37+00:00", "published_display": "11 Jul 2026 02:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/goodrx-announces-date-second-quarter-200500134.html", "source_name": "Business Wire", "published_at": "2026-07-09T20:05:00+00:00", "published_display": "09 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx sets Aug. 5 earnings release, Aug. 6 call", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeHFIQWt1Sk1QbGpkd0hfRUdtWndnaFdZdFJqTURjS0Y4TlpIMFc5TEhmLVVQVEpXa1d2RUg3N1pVbVJDVkNTSHgzRUEyTTZpNE9jc1FmQlZNdzBKTWpyQk9nLXRoRFV2cEl0VmNSSE8xMzdnZ1gyLTlDemhiY0poRzl2VnBXV3lBdW1lMFFpTjdVdENJcjNDekVRWHh6b2x4V09NSThwN3h1bVJCNVd4bXhpS3BObkJDdFhxMGVNMA?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-09T20:05:00+00:00", "published_display": "09 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) Upgraded to Buy: What Does It Mean for the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQdkwtcU1RaWF2MzFhOUI4eDdEeUJUZEJqMnFvWjNGS1VEQWJ2cm9sT1BVOEtla1dxMGNRSVFodm0yT1ZrVjVJakdmN1dGWHc1ZExRdkhzTmh4Z1lmMHEzSUNXVnFDcGxvUm5EWmlsWF8wZGNYS0oxNEp2aGhyM0Y0R2J3QVBldDA1eHlKLURPdU9EX1ZjTDg3ZFBB?oc=5", "source_name": "Market source", "published_at": "2026-07-08T16:00:03+00:00", "published_display": "08 Jul 2026 16:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is GoodRx (GDRX) Stock Undervalued Right Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQX1JFcVFpUE5Uck40aGs3U1hhdzh0ME1UQXR6ZUlUNkVRbllYd28ybkNzcUpkYkFJam5MLV9NSnVCbV8wWE1FQ0xMc1ZrTFFhSWVDakFMUVpFS1hCU3g5MW1fbkl4eE9ESzZSbXROSU5UT2oyUnU2ZWs4VUpXaHpjSGlfWHdpWkxZVGYzNC1TaVNCRDI4RHBIOXpROGtvNFE?oc=5", "source_name": "Market source", "published_at": "2026-07-08T13:40:05+00:00", "published_display": "08 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 Penny Stocks Under $8B Market Cap Worth Watching", "summary": "This article highlights three penny stocks with market caps under $8 billion that are worth watching, despite the current positive trend in the U.S. market. It examines GoodRx Holdings (GDRX), CI&T (CINT), and Snap (SNAP), detailing their financial health, operational revenue, an", "url": "https://www.sahmcapital.com/news/content/3-penny-stocks-under-8b-market-cap-worth-watching-2026-07-02", "source_name": "Sahm", "published_at": "2026-07-03T11:10:50", "published_display": "03 Jul 2026 11:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings, Inc. Class A Actuals & Estimates (NASDAQ:GDRX)", "summary": "This article provides a detailed financial overview and analyst estimates for GoodRx Holdings, Inc. (NASDAQ: GDRX). It covers stock performance, price targets, earnings reports, revenue, market capitalization, and volatility. The company's stock price recently decreased by -2.54%", "url": "https://www.tradingview.com/symbols/NASDAQ-GDRX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T22:09:44", "published_display": "25 Jun 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings elects directors and ratifies auditor at annual meeting", "summary": "GoodRx Holdings, Inc. held its Annual Meeting of Stockholders, where shareholders elected three Class III directors, ratified KPMG LLP as its independent auditor for fiscal year 2026, and approved executive officer compensation on an advisory basis. The company, trading at $2.68 ", "url": "https://m.uk.investing.com/news/sec-filings/goodrx-holdings-elects-directors-and-ratifies-auditor-at-annual-meeting-93CH-4736637?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-19T03:09:53", "published_display": "19 Jun 2026 03:09", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) investors re-elect board and ratify KPMG, back pay", "summary": "GoodRx Holdings, Inc. announced the results of its annual stockholder meeting held on June 16, 2026. Stockholders re-elected Wendy Barnes, Ronald E. Bruehlman, and Gregory Mondre as Class III directors, ratified KPMG LLP as the independent registered public accounting firm for th", "url": "https://www.stocktitan.net/sec-filings/GDRX/8-k-good-rx-holdings-inc-reports-material-event-4cd731979f51.html", "source_name": "Stock Titan", "published_at": "2026-06-18T20:05:56", "published_display": "18 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) director receives 73,434 RSUs vesting by 2027 meeting", "summary": "GoodRx Holdings director Kelly J. Kennedy received an equity award of 73,434 restricted stock units (RSUs) of Class A common stock, which were granted at no cash cost. These RSUs will vest in full on the earlier of the one-year anniversary of June 16, 2026, or the 2027 Annual Mee", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-52d989798886.html", "source_name": "Stock Titan", "published_at": "2026-06-18T00:39:22", "published_display": "18 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) director Trevor Bezdek granted 73,434 RSUs and updates holdings", "summary": "GoodRx Holdings director Trevor Bezdek was granted 73,434 restricted stock units (RSUs) as compensation, vesting on June 16, 2026, or the 2027 Annual Meeting, subject to continued service. Following this grant, Bezdek directly holds 343,810 Class A shares and has indirect interes", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-d999e5fff231.html", "source_name": "Stock Titan", "published_at": "2026-06-18T00:39:22", "published_display": "18 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] GoodRx Holdings, Inc. Insider Trading Activity", "summary": "GoodRx Holdings, Inc. director Ronald E. Bruehlman reported an acquisition of 73,434 deferred stock units, increasing his direct holdings to 207,352 shares. These units vest on the earlier of one year from June 16, 2026, or the 2027 Annual Meeting, and settle into shares upon spe", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-2a7cc51fa8cf.html", "source_name": "Stock Titan", "published_at": "2026-06-18T00:39:22", "published_display": "18 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) director Douglas Hirsch receives 73,434 deferred stock units in equity grant", "summary": "GoodRx Holdings, Inc. director Douglas Hirsch has been granted 73,434 deferred stock units as part of an equity compensation package. These units, which represent a right to one share each, will vest on the earlier of June 16, 2027, or the company's 2027 annual stockholders' meet", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-2b4a3cf73f0b.html", "source_name": "Stock Titan", "published_at": "2026-06-18T00:39:22", "published_display": "18 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNVGpad3dmTHRtWXJHdGpSLUR2MzMyNXg2OXNLVnZ2N0p5SmE0SGdtX2lfTV9uZmNsY25Ha0JHU21wMk9GQVhPQzB6cTdqcFkyOXJKbE5jVEUwYU5OUGdqWDFUc0tLb1BnWUVsbHctTVRpNERQUl9objFTejVocG5TeEZKZGx6RUdzRmczdmNNQTlScHViQXV5ZVg4eFAzQQ?oc=5", "source_name": "Market source", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) AGM 2026 Summary", "summary": "This article summarizes the GoodRx (GDRX) Annual General Meeting (AGM) held on June 16, 2026. Key agenda items included the nomination of Class C directors, ratification of KPMG LLP as the auditor, and advisory approval of executive compensation. The report also highlights recent", "url": "https://quartr.com/events/goodrx-holdings-inc-gdrx-agm-2026_3eoBJCXW", "source_name": "Quartr", "published_at": "2026-06-16T23:09:52", "published_display": "16 Jun 2026 23:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings Inc (GDRX) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for GoodRx Holdings Inc (GDRX), highlighting its current earnings forecast score of 6.67 and an average price target of $5.00 from 15 analysts. The company's expected revenue for the next quarter is $193.16 million, with most analysts re", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-gdrx/earnings", "source_name": "TradingKey", "published_at": "2026-06-16T12:09:52", "published_display": "16 Jun 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) Chief Accounting Officer exercises RSUs, shares withheld for taxes", "summary": "GoodRx Holdings, Inc.'s Chief Accounting Officer, Thomas Chan, engaged in routine equity compensation activity, exercising 4,069 restricted stock units (RSUs) into Class A common stock on June 15, 2026. To cover tax obligations arising from this transaction, 2,071 shares were wit", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-41dfdc4ad25c.html", "source_name": "Stock Titan", "published_at": "2026-06-15T20:39:57", "published_display": "15 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trevor Bezdek (GDRX) receives 110K RSUs vesting in 2027", "summary": "GoodRx Holdings, Inc. director Trevor Bezdek was granted 110,294 restricted stock units (RSUs), each representing one share of Class A common stock, at a price of $0.00 per unit. These RSUs will vest 100% on December 31, 2027, contingent on his continued service. Following this t", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-cd77d741b299.html", "source_name": "Stock Titan", "published_at": "2026-06-11T00:39:05", "published_display": "11 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings, Inc. (GDRX) Strengthens Recurring Revenue Base with Companion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPeURzb1hUX2NOSG9CZGUza3NQdExnSXNMTXdDNndBZjNmdGdUUk15UVRPRmMxWTZOWEM4OEQtcGJ1bzJxVjZkMTY2ZVhFODIxcTFGbUdpdnhLMnJtWTAtcVFpR1lIa2ZkdzdPOUFBT0FtNUVuTVdqZG9McGN2bTlFbWdjMXBDM1ppYTBnNWVzRnE4TDdqUndsYjZYZ09vVldaVHBv?oc=5", "source_name": "Market source", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) director receives 4,642 deferred stock units", "summary": "GoodRx (NASDAQ: GDRX) director Ronald E. Bruehlman was granted 4,642 deferred stock units at no cash cost. These units, representing a contingent right to one share of Class A common stock each, will vest 2% on May 31, 2026, with the remainder vesting monthly over seven months, s", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-aa5b7fe78e45.html", "source_name": "Stock Titan", "published_at": "2026-05-29T22:09:25", "published_display": "29 May 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) director grant adds 4,642 deferred stock units", "summary": "GoodRx Holdings, Inc. director Douglas Joseph Hirsch was granted 4,642 deferred stock units at a price of $0.00 per share on May 27, 2026. This grant increases his direct holdings to 247,502 shares of Class A common stock. The units have a vesting schedule where 2% vest on May 31", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-12abd72f3327.html", "source_name": "Stock Titan", "published_at": "2026-05-29T22:09:24", "published_display": "29 May 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Shifting Story For GoodRx (GDRX) Is Reshaping Analyst Views And Valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQc3VvczZQbjFzbWFiYlR4MXJWSUJsY0Q3SC1fZi0wbkRQVmRxaHM2NFVMRGdhZVBCZHFWd2ZBZjhxOUx3VVRoVUYtVFY5S1pPYUdPVmRpMS1ZUWp3U01DT0lvdUt1eVFfdjRuVFFIT1RJVm8xU3laalRGZUlIUXg4d29LaUlad181czZyN3k4cVV5QjhFcl9vWXVrTnVSbGQ1WnBZ?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx: TrumpRx Exposes Legacy Moat Breach And Zero-Sum Strategy (Downgrade) (NASDAQ:GDRX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNUzF1UzVSRlRSM1VpQlo3VHViekRLOTJWaDFXZEI3bjNUNi05QllpeE1KcWJaY01VaUZhVGpWUHEwY3RiQTgzeFlaV3VPdXh2aWMwcnVnWElQaUpGVkc0QVFVRjdVVU44WnkyS19sa2J5bjBFUGh5SmpuY01nSnlqd2pvWDdzcnUtWDVodURfZjdCRFhMZFNKdHZlWXVCQS1YQl9EckJONVlOVkw5cU5hc3lfVTA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) CAO exercises RSUs and delivers shares to cover taxes", "summary": "GoodRx Holdings, Inc.'s Chief Accounting Officer, Thomas Chan, exercised 5,575 restricted stock units, converting them into Class A common stock. To cover tax obligations related to these vestings, 2,838 shares were disposed of at $2.49 per share through a non-market, tax-withhol", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-8bdf0acb693b.html", "source_name": "Stock Titan", "published_at": "2026-05-15T21:10:03", "published_display": "15 May 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) executive exercises 44,779 RSUs, 19,726 shares for taxes", "summary": "GoodRx Holdings executive Christopher A. McGinnis exercised 44,779 restricted stock units to acquire Class A common stock and concurrently surrendered 19,726 shares to cover tax obligations. These routine transactions are related to equity compensation and not open-market sales. ", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-76881d2d802e.html", "source_name": "Stock Titan", "published_at": "2026-05-15T21:10:03", "published_display": "15 May 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Some May Be Optimistic About GoodRx Holdings' (NASDAQ:GDRX) Earnings", "summary": "Despite soft profit numbers, GoodRx Holdings' recent earnings report pleased the market due to signs of underlying promise. The company's profit was notably reduced by US$14 million due to unusual, likely one-off, items, suggesting its true earnings potential might be understated", "url": "https://www.sahmcapital.com/news/content/some-may-be-optimistic-about-goodrx-holdings-nasdaqgdrx-earnings-2026-05-14", "source_name": "Sahm", "published_at": "2026-05-15T04:39:28", "published_display": "15 May 2026 04:39", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Jim Cramer Says 'Pull The Trigger' On Chevron", "summary": "Jim Cramer recommends buying Chevron (CVX) due to its strong cash flow, 3.8% yield, and the fact that its stock was significantly higher the last time oil prices were at current levels. He also commented on GoodRx, Vertiv, and Sterling Infrastructure, advising caution for the lat", "url": "https://www.sahmcapital.com/news/content/why-jim-cramer-says-pull-the-trigger-on-chevron-2026-05-13", "source_name": "Sahm", "published_at": "2026-05-13T21:09:04", "published_display": "13 May 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) awards 54,494 RSUs to Chief Accounting Officer Thomas Chan", "summary": "GoodRx Holdings, Inc. has granted 54,494 restricted stock units (RSUs) to its Chief Accounting Officer, Thomas Chan. These RSUs represent a contingent right to receive one share of Class A common stock each. The award will vest in 1/12 increments quarterly, beginning on August 15", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-dd3c780fba9d.html", "source_name": "Stock Titan", "published_at": "2026-05-12T23:09:03", "published_display": "12 May 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GDRX (NASDAQ: GDRX) Form 144 \u2014 43,100-share proposed sale", "summary": "Morgan Stanley Smith Barney LLC Executive Financial Services has filed a Form 144 to report a proposed sale of 43,100 shares of Common stock for GoodRx Holdings, Inc. (NASDAQ: GDRX). The shares are comprised of two restricted stock lots dated June 3, 2025 (25,852 shares) and July", "url": "https://www.stocktitan.net/sec-filings/GDRX/144-good-rx-holdings-inc-sec-filing-e475815d10b2.html", "source_name": "Stock Titan", "published_at": "2026-05-12T14:40:57", "published_display": "12 May 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx vs. Hims & Hers Health: Stagnation vs. Growth in Revenue", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNdjFVYXBnbmItZi1qeE5zNFR2aVNuZ21pTDltUmFLVDd1Snc2NG9BMzlNWmxaM3RERV9oRlBoeHN6cllRNkFZeDBual9vTE93cE4tZHBubHFPR0RsVEpnckYzQXJ5T1AtNlltNHZKYTRhSV9idGdLMEpiNW5HdkZ3QmhFQ2IxbXBQU1ZCN0tvSHZSUUpxNXZuSGMzY3NzZnFPcnVmbXNhanJadU0?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings (GDRX) Thin Q1 Profit Margins Test Bullish Earnings Growth Narratives", "summary": "GoodRx Holdings (GDRX) reported Q1 2026 revenue of US$194.0 million and basic EPS of US$0.00, with trailing net profit margins at 2.6%. Despite analyst forecasts for 26.2% earnings growth, current thin margins, a one-off US$18.7 million loss, and a high P/E ratio compared to peer", "url": "https://www.sahmcapital.com/news/content/goodrx-holdings-gdrx-thin-q1-profit-margins-test-bullish-earnings-growth-narratives-2026-05-08", "source_name": "Sahm", "published_at": "2026-05-09T02:09:27", "published_display": "09 May 2026 02:09", "sentiment": "negative", "sentiment_pct": 35, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Reports First Quarter 2026 Results", "summary": "GoodRx Holdings, Inc. announced its financial results for the first quarter of 2026, reporting revenue of $194.0 million and net income of $1.2 million. While overall revenue decreased by 4% year-over-year, its Pharma Direct revenue saw an 82% increase, and subscription revenue g", "url": "https://www.businesswire.com/news/home/20260506399684/en/GoodRx-Reports-First-Quarter-2026-Results", "source_name": "Business Wire", "published_at": "2026-05-08T02:09:48", "published_display": "08 May 2026 02:09", "sentiment": "positive", "sentiment_pct": 69, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) Q1 2026 shifts from Rx volume to Pharma Direct growth", "summary": "GoodRx Holdings, Inc. (NASDAQ: GDRX) reported a shift in revenue composition for Q1 2026, with overall revenue slightly decreasing to $194.0 million from $203.0 million year-over-year. The core prescription transactions business saw a 24% decline, attributed to fewer Monthly Acti", "url": "https://www.stocktitan.net/sec-filings/GDRX/10-q-good-rx-holdings-inc-quarterly-earnings-report-e3ba8aa22a00.html", "source_name": "Stock Titan", "published_at": "2026-05-07T06:10:33", "published_display": "07 May 2026 06:10", "sentiment": "negative", "sentiment_pct": 41, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) grows Pharma Direct and lifts 2026 outlook", "summary": "GoodRx reported Q1 2026 revenue of $194.0 million, a 4% decrease year-over-year, largely due to a 24% decline in prescription transactions revenue. However, Pharma Direct revenue surged 82% to $52.2 million, and subscription revenue increased 16% to $24.4 million, reflecting a st", "url": "https://www.stocktitan.net/sec-filings/GDRX/8-k-good-rx-holdings-inc-reports-material-event-3079d56a2c62.html", "source_name": "Stock Titan", "published_at": "2026-05-07T03:10:10", "published_display": "07 May 2026 03:10", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQZkJoajlsNnhqUHZhRWx3ZUw2RnU3dWNEeFl2WlVjb2dZM21RRmFTRm15TUdCVkxGUXJ4Xy1wSW1NSE1qVzJoUGY0S0lBVXcwTGFnVE1BbHk4OEFmX2xUUzdfMXBySW8zblZJcEo0djJSUVVmZi1tbWxfb1NmVjh3S1JrNnBINmt3WEsybDFqeXd5NFkxYTJj?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why GoodRx (GDRX) Stock Is Trading Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQaGd5T3I5R01sdUtMeEpZOTRFX2RfbERHSjlHcFB4OURjQzdNakZiRFJ5NGlONmZEaGQ0WGNhdjVBNVpfTElmWEF0STFJTmZLbFhTWlExaXRpOTlBTjJQREg0WFRkWEpFWGd0Y0psSXpjRDk1dDg1QkFFSEs3dHE2aFpXN3JVUkZzOERZWGtTNHRqY3pFcGM4TTlR?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) CAO Thomas Chan reports stock, options and RSUs", "summary": "GoodRx Holdings, Inc. Chief Accounting Officer Thomas Chan has filed an initial ownership report (Form 3) detailing his holdings in the company. The filing indicates direct ownership of 1,000 Class A common shares, multiple stock options with varying exercise prices and expiratio", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-3-good-rx-holdings-inc-initial-statement-of-beneficial-ownership-cf5f7f2a3511.html", "source_name": "Stock Titan", "published_at": "2026-05-01T21:39:08", "published_display": "01 May 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Executive pay, auditor change headline GoodRx (NASDAQ: GDRX) 2026 vote", "summary": "GoodRx Holdings, Inc. (NASDAQ: GDRX) is holding its 2026 virtual Annual Meeting of Stockholders on June 16, 2026. Key agenda items include the election of three Class III directors, the ratification of KPMG LLP as the independent registered public accounting firm, and an advisory", "url": "https://www.stocktitan.net/sec-filings/GDRX/def-14a-good-rx-holdings-inc-definitive-proxy-statement-d267c45a2b03.html", "source_name": "Stock Titan", "published_at": "2026-04-30T11:09:22", "published_display": "30 Apr 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Going On With GoodRx Stock Thursday?", "summary": "GoodRx Holdings, Inc. (NASDAQ: GDRX) shares are gaining premarket following the announcement of expanding access to Eli Lilly and Company\u2019s (NYSE: LLY) new oral GLP-1 medication, Foundayo, starting at $149 per month. The company is also expanding access to Zepbound, available sta", "url": "https://www.sahmcapital.com/news/content/whats-going-on-with-goodrx-stock-thursday-2026-04-09", "source_name": "Sahm", "published_at": "2026-04-28T02:09:09", "published_display": "28 Apr 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Technology Stocks Q4 Recap: Benchmarking GoodRx (NASDAQ:GDRX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQdE5Udjk5ajVJc1hXS3RLLXAyc3otNnc5am9paGZHbllYSkVwSDVyN2wwQnI4Z3BKWWEzQmQtMXNuVVFEbzd6UlBlOU9nQmFhU2RRWEVzYWU2LW5IdUVhUXQ5SDRqbnI1azVHVU45cGdoN2pOMFFnOFpEWXVwMGhFRW1TX2ppU0RtVUo2VTRhYlNvR1hrcFVNQk93Z3FqOU1TNjFWODNvZDM3dw?oc=5", "source_name": "Market source", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A higher-dose Wegovy now costs $399 a month through GoodRx", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOekZTSF9SLVJYVE1mT29WZzR1Nnk5dHZNY3hnY01SOWE0cEt6djF5dTVmVkVic1RsS0h3Y2xmS0hPWi1UUVRsZ0FqMTlKMkhOUzAzek5ZSjJ4VWJtZ3pMdFk1UGVaYlY4TjlwckIwOTBMaTFNb0daWkdJNFFZdmwydENCcjNtcTBYQjFFd0I4SHRnV29qeVBHalQ5YmhySDJzMnFDZmpGWVFib1RIOGtxemFhdldYaWgxME5N?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why GoodRx (GDRX) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQZ0h0bUREaXM4a1VnLTJ3M3dSV01SSkx5ZmZkczhIWER5cXBRTnd4MmppMUN3VVVxSl9rQ25RSDB2a3lhVkZveUR6eFFqeFV6ak1saEVPLVJmNXBMb05sR1B4QzNRVE9ZUGVycjhpcThpQklyMk9KdWdLbjZnN3pEdlRDd25xaFVsZlFiN3k0V21sa3lOZDVv?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx brings Lilly's new weight-loss pill to pharmacies nationwide", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNTnVoNTJTb1BLSE9KbE81ZEpINFQxOGszU013aHJiX0FZTk9oc0JxNjh1WjdhZHFSeGJGd2ZOTmxIWnpXVDFQYXFoZWxYcmdwUnFQZ0pfaFpsMVlXRXlPSnF5VG9aS19fNW9qTElIWDByaUdOOTZmcGl6QzllQ054QWRTUmx5Y3kwUGU1SG03S1ZCcGliRmUzc1d6M05JU3lKbUdBRGtxY0hKX21KSzVxWWgtOWVHak84dHE0?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is GoodRx (GDRX) Using Employer Direct to Redefine Its Role in Workplace Drug Benefits?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-01T08:00:00+00:00", "published_display": "01 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx\u2019s (NASDAQ:GDRX) Q4 CY2025 Sales Top Estimates But Stock Drops 11.8%", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE1PNUQ0QWVJVWRDX0FtcnJrSW5mV3VtdmlYWHczMEFXRDNBTW9PYVRXZ2RUU2J3SVBudmVWaDR2N19GYkRMUXlJZ0FZa1pwejh1cG1iSDJiV2dFZGF5WTFqMGtRMHdlRkFFdjV2aDBXOXRPdUpoSU5BcWlnb0JFZzg?oc=5", "source_name": "Market source", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX): Buy, Sell, or Hold Post Q3 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE0yNnZCWGlzSXpSbkx1eDdLSi1jUzZULXYxWVdkY2dOUFVDUkREMUFOLVNMbjhwWnBfYmFpT1hPaFlPYmtJRjhSc3pCTndRV0JKcGJBNWVvT2d4b3EyejJVNEp5azhWWEpWZnBUNlNFTUFJeExTQTQ1NXhvOA?oc=5", "source_name": "Market source", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings, Inc.'s (NASDAQ:GDRX) biggest owners are retail investors who got richer after stock soared 7.5% last week", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-07T08:00:00+00:00", "published_display": "07 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-19T08:00:00+00:00", "published_display": "19 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Offers FDA-Approved Wegovy Pill at $149 Monthly Cash Price Across US Pharmacies", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOYlpadFhLcGZyUzZtSTVFNVRMVDBFdGM4ZXdmQVVtbThkMGtMdEFmWkJCVDRNMXhMUVdWYlNuemlKb3ZRbUR1VHhJc0lhMW9SYVV1X1hwcTV5X0pWR2ZsZl9ubkxxMkwxMllsVDhQSmtBVmJfOFdYNzhuSUxTdHVsRk1TdU9RTmZiMFZKMEVGQlM1ejZuc1B2cUVRRXZCaE9zXzZHQy13?oc=5", "source_name": "Pharmaceutical Commerce", "published_at": "2026-01-05T08:00:00+00:00", "published_display": "05 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How GoodRx, Texas A&M, and 2 other brands are setting examples for U.S.-based companies", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOQm1IbUYtbGJHQWh6MnZZX0N5Mm5pcFEtV1F2cFhpNjZGNnBTT1VxUm5XdHpkV3drNVp5ZlRyTk44RERERzd3MjQ1bV9XaWxtVEJmTlNtOXhzcTF0akF0UktycnpYMkRRbUVMamo2VGNRSl9kdV96d2wxV0txbmRVbGhhbF8yeENxbnJobUMycUEwYWdfY3Z6Mkx2RW1VaDFna3BvUkJKMUp1Rzg?oc=5", "source_name": "Fast Company", "published_at": "2025-12-02T08:00:00+00:00", "published_display": "02 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Don't See Light At End Of GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Tunnel And Push Stock Down 33%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-01T07:00:00+00:00", "published_display": "01 Nov 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Does GoodRx Make Money?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQNWt1aW1iQWZMNkJHbEdmNlNjVjZLemszeTNvdlM2M2ptRlpJdXVxcjQ4VEJHYmRtNFhQYU42MEJpR0IxZXFnVmJZczZYaGMzX2xleGxCMTVqcDJubWpQUUdNVS1PeG5CZVl1OGd4UEVwNmhRMmtveFNGckNwWVZOaC1HMkVpZw?oc=5", "source_name": "The Motley Fool", "published_at": "2025-10-18T07:00:00+00:00", "published_display": "18 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx stock climbs on potential TrumpRx partnership, expanded Kroger tie-up", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPWU1yb3R6ZXJzT1AzblhRaEhZcWJhZ2VSVFNVMmFsM1VzMDVJQ0xBZ0hrc0RfWWV6REI3ZkdjQ1Y3bkNEVU1reVNub0JyWHNEMTZ1RXRIT2Z1ek5CMXdqSlFIaGxZZ2k4MzNwd0hlX19jekNKNVNrMlpmVkVpREl4aWxVVFlEdlN6OWlSSFlLdG00RFJvM3J6MzB2LVB6bGlsT1lKMHFIczdFM2RvVnI1RUhucFVOWmc?oc=5", "source_name": "Fierce Healthcare", "published_at": "2025-10-03T07:00:00+00:00", "published_display": "03 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/stocks-making-big-moves-yesterday-200711198.html", "source_name": "StockStory", "published_at": "2026-07-14T20:07:11+00:00", "published_display": "14 Jul 2026 20:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPN2NESkluMlFsRTBKM3NUOUN5WkJkMlQ1bE9ieDdWcTJPRnZDWFBVclp4X2ZOWUdSblRwMlFVdXNYRlloSHVqMFFLWHF3RHk2SWJaUndZSEVMdTd4Z2dHa2x1bWFid3p4RFJnNktINXJyVDBHSE9IazEzakFHa1Zud0V4N2pWNnZiMUVHUGI5UlU1dG1DWE1BTw?oc=5", "source_name": "Market source", "published_at": "2026-07-13T23:50:39+00:00", "published_display": "13 Jul 2026 23:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings (GDRX) Pharma Growth Story Meets A Small Fair Value Gap", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPQ3NsZTBqNWExRmVmSWMxcDE3NWRMeThvbTJvQnRSMlBQMjVDOW1nWEluNmFKaW5HOHVxc1RYXzJESG1KaGNfd0dFOXQzaFlaSVpsTXZHQ2lRNVlRcTlJTHZ6eGtKUFRKdWQwd0t4YkpTb3ZINGRic3U0YzktNFBpdk5VQ0R6aTVRQS0tNGxDbzlsUHZvZGc3bU5MdFRuSzJZ?oc=5", "source_name": "Market source", "published_at": "2026-07-12T05:07:00+00:00", "published_display": "12 Jul 2026 05:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) Stock Looks Full On Earnings But Mixed On Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOM2E3NW5vY3hZNXF0bUx6cFBtMlAyN2ZsWHk1bmlhazVzRFM3ZGd2SzRQRXhaZ0JWTXJNb1V5eVU4bWZFdmlZRmNMcjdiRjlRNTVBa1V1MHNTWlVXSThvTGdkMUpXSVlYMUhoS3pmdEdZN3dXd1VSQXV0dHEtWTY3MTdSRlpKamhFcUFMVmpESW5sZ0RzazZUcg?oc=5", "source_name": "Market source", "published_at": "2026-07-11T07:10:18+00:00", "published_display": "11 Jul 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings (GDRX) Sets Q2 Results Date, Is The Stock Still Undervalued?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQSGtIZzluSWNJZUx4a1ZaYmlWWEFJaGFGUkU0VVR0d1NDTmpDVFdqNURMX1AzMG4xbVN6VkJXdUE0WkNlSG9nTExGQXZ0dVI2eXJPN1gtbVlBTGJGeGhOUFpfRXM1bmV2cDFROGYtUWFoWjFCMTFnRlpLZVBYS3VzS3hoazdZNDdZcHNEZ284azRVZTRfZUJCMWU1Mnp1MmRDdWpvdm9Kd3ZDbUpZenhWMVo4Vm5JTzlDMVNaakhYdTJGc3hXOGdVbmdKeTR6OW1uU2fSAdcBQVVfeXFMTnBSQ3lGRUo1LXp2MVo5c3ZYSDRpYVppbXJVcEdCZ1BRNjdNd0ctcnRubi1NQlYzTE1XOF93d3BYWV9uQ0VkdTQtMTBXODNsQ0VXYnlMMWI3M1RIa2FZeHh2NmFaa29lc3d4ZFJpRWR0aDN4aHlEekUxZ3RoWndnOFlvTVhFcmRIeFM4YTBiWWZWNEhtajhHX3lwTHNKTU56TUdWTjVENlJ6ajRsY1hTbHpEaWQ0RjRHNnAxN0swMHdJb0xqNlJ3akNIcU0zbG1XQkhqVkZJTFk?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T02:31:37+00:00", "published_display": "11 Jul 2026 02:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/goodrx-announces-date-second-quarter-200500134.html", "source_name": "Business Wire", "published_at": "2026-07-09T20:05:00+00:00", "published_display": "09 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx sets Aug. 5 earnings release, Aug. 6 call", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeHFIQWt1Sk1QbGpkd0hfRUdtWndnaFdZdFJqTURjS0Y4TlpIMFc5TEhmLVVQVEpXa1d2RUg3N1pVbVJDVkNTSHgzRUEyTTZpNE9jc1FmQlZNdzBKTWpyQk9nLXRoRFV2cEl0VmNSSE8xMzdnZ1gyLTlDemhiY0poRzl2VnBXV3lBdW1lMFFpTjdVdENJcjNDekVRWHh6b2x4V09NSThwN3h1bVJCNVd4bXhpS3BObkJDdFhxMGVNMA?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-09T20:05:00+00:00", "published_display": "09 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) Upgraded to Buy: What Does It Mean for the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQdkwtcU1RaWF2MzFhOUI4eDdEeUJUZEJqMnFvWjNGS1VEQWJ2cm9sT1BVOEtla1dxMGNRSVFodm0yT1ZrVjVJakdmN1dGWHc1ZExRdkhzTmh4Z1lmMHEzSUNXVnFDcGxvUm5EWmlsWF8wZGNYS0oxNEp2aGhyM0Y0R2J3QVBldDA1eHlKLURPdU9EX1ZjTDg3ZFBB?oc=5", "source_name": "Market source", "published_at": "2026-07-08T16:00:03+00:00", "published_display": "08 Jul 2026 16:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is GoodRx (GDRX) Stock Undervalued Right Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQX1JFcVFpUE5Uck40aGs3U1hhdzh0ME1UQXR6ZUlUNkVRbllYd28ybkNzcUpkYkFJam5MLV9NSnVCbV8wWE1FQ0xMc1ZrTFFhSWVDakFMUVpFS1hCU3g5MW1fbkl4eE9ESzZSbXROSU5UT2oyUnU2ZWs4VUpXaHpjSGlfWHdpWkxZVGYzNC1TaVNCRDI4RHBIOXpROGtvNFE?oc=5", "source_name": "Market source", "published_at": "2026-07-08T13:40:05+00:00", "published_display": "08 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 Penny Stocks Under $8B Market Cap Worth Watching", "summary": "This article highlights three penny stocks with market caps under $8 billion that are worth watching, despite the current positive trend in the U.S. market. It examines GoodRx Holdings (GDRX), CI&T (CINT), and Snap (SNAP), detailing their financial health, operational revenue, an", "url": "https://www.sahmcapital.com/news/content/3-penny-stocks-under-8b-market-cap-worth-watching-2026-07-02", "source_name": "Sahm", "published_at": "2026-07-03T11:10:50", "published_display": "03 Jul 2026 11:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings, Inc. Class A Actuals & Estimates (NASDAQ:GDRX)", "summary": "This article provides a detailed financial overview and analyst estimates for GoodRx Holdings, Inc. (NASDAQ: GDRX). It covers stock performance, price targets, earnings reports, revenue, market capitalization, and volatility. The company's stock price recently decreased by -2.54%", "url": "https://www.tradingview.com/symbols/NASDAQ-GDRX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T22:09:44", "published_display": "25 Jun 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings elects directors and ratifies auditor at annual meeting", "summary": "GoodRx Holdings, Inc. held its Annual Meeting of Stockholders, where shareholders elected three Class III directors, ratified KPMG LLP as its independent auditor for fiscal year 2026, and approved executive officer compensation on an advisory basis. The company, trading at $2.68 ", "url": "https://m.uk.investing.com/news/sec-filings/goodrx-holdings-elects-directors-and-ratifies-auditor-at-annual-meeting-93CH-4736637?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-19T03:09:53", "published_display": "19 Jun 2026 03:09", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) investors re-elect board and ratify KPMG, back pay", "summary": "GoodRx Holdings, Inc. announced the results of its annual stockholder meeting held on June 16, 2026. Stockholders re-elected Wendy Barnes, Ronald E. Bruehlman, and Gregory Mondre as Class III directors, ratified KPMG LLP as the independent registered public accounting firm for th", "url": "https://www.stocktitan.net/sec-filings/GDRX/8-k-good-rx-holdings-inc-reports-material-event-4cd731979f51.html", "source_name": "Stock Titan", "published_at": "2026-06-18T20:05:56", "published_display": "18 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) director receives 73,434 RSUs vesting by 2027 meeting", "summary": "GoodRx Holdings director Kelly J. Kennedy received an equity award of 73,434 restricted stock units (RSUs) of Class A common stock, which were granted at no cash cost. These RSUs will vest in full on the earlier of the one-year anniversary of June 16, 2026, or the 2027 Annual Mee", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-52d989798886.html", "source_name": "Stock Titan", "published_at": "2026-06-18T00:39:22", "published_display": "18 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) director Trevor Bezdek granted 73,434 RSUs and updates holdings", "summary": "GoodRx Holdings director Trevor Bezdek was granted 73,434 restricted stock units (RSUs) as compensation, vesting on June 16, 2026, or the 2027 Annual Meeting, subject to continued service. Following this grant, Bezdek directly holds 343,810 Class A shares and has indirect interes", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-d999e5fff231.html", "source_name": "Stock Titan", "published_at": "2026-06-18T00:39:22", "published_display": "18 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] GoodRx Holdings, Inc. Insider Trading Activity", "summary": "GoodRx Holdings, Inc. director Ronald E. Bruehlman reported an acquisition of 73,434 deferred stock units, increasing his direct holdings to 207,352 shares. These units vest on the earlier of one year from June 16, 2026, or the 2027 Annual Meeting, and settle into shares upon spe", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-2a7cc51fa8cf.html", "source_name": "Stock Titan", "published_at": "2026-06-18T00:39:22", "published_display": "18 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) director Douglas Hirsch receives 73,434 deferred stock units in equity grant", "summary": "GoodRx Holdings, Inc. director Douglas Hirsch has been granted 73,434 deferred stock units as part of an equity compensation package. These units, which represent a right to one share each, will vest on the earlier of June 16, 2027, or the company's 2027 annual stockholders' meet", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-2b4a3cf73f0b.html", "source_name": "Stock Titan", "published_at": "2026-06-18T00:39:22", "published_display": "18 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNVGpad3dmTHRtWXJHdGpSLUR2MzMyNXg2OXNLVnZ2N0p5SmE0SGdtX2lfTV9uZmNsY25Ha0JHU21wMk9GQVhPQzB6cTdqcFkyOXJKbE5jVEUwYU5OUGdqWDFUc0tLb1BnWUVsbHctTVRpNERQUl9objFTejVocG5TeEZKZGx6RUdzRmczdmNNQTlScHViQXV5ZVg4eFAzQQ?oc=5", "source_name": "Market source", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) AGM 2026 Summary", "summary": "This article summarizes the GoodRx (GDRX) Annual General Meeting (AGM) held on June 16, 2026. Key agenda items included the nomination of Class C directors, ratification of KPMG LLP as the auditor, and advisory approval of executive compensation. The report also highlights recent", "url": "https://quartr.com/events/goodrx-holdings-inc-gdrx-agm-2026_3eoBJCXW", "source_name": "Quartr", "published_at": "2026-06-16T23:09:52", "published_display": "16 Jun 2026 23:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings Inc (GDRX) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for GoodRx Holdings Inc (GDRX), highlighting its current earnings forecast score of 6.67 and an average price target of $5.00 from 15 analysts. The company's expected revenue for the next quarter is $193.16 million, with most analysts re", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-gdrx/earnings", "source_name": "TradingKey", "published_at": "2026-06-16T12:09:52", "published_display": "16 Jun 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) Chief Accounting Officer exercises RSUs, shares withheld for taxes", "summary": "GoodRx Holdings, Inc.'s Chief Accounting Officer, Thomas Chan, engaged in routine equity compensation activity, exercising 4,069 restricted stock units (RSUs) into Class A common stock on June 15, 2026. To cover tax obligations arising from this transaction, 2,071 shares were wit", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-41dfdc4ad25c.html", "source_name": "Stock Titan", "published_at": "2026-06-15T20:39:57", "published_display": "15 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trevor Bezdek (GDRX) receives 110K RSUs vesting in 2027", "summary": "GoodRx Holdings, Inc. director Trevor Bezdek was granted 110,294 restricted stock units (RSUs), each representing one share of Class A common stock, at a price of $0.00 per unit. These RSUs will vest 100% on December 31, 2027, contingent on his continued service. Following this t", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-cd77d741b299.html", "source_name": "Stock Titan", "published_at": "2026-06-11T00:39:05", "published_display": "11 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings, Inc. (GDRX) Strengthens Recurring Revenue Base with Companion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPeURzb1hUX2NOSG9CZGUza3NQdExnSXNMTXdDNndBZjNmdGdUUk15UVRPRmMxWTZOWEM4OEQtcGJ1bzJxVjZkMTY2ZVhFODIxcTFGbUdpdnhLMnJtWTAtcVFpR1lIa2ZkdzdPOUFBT0FtNUVuTVdqZG9McGN2bTlFbWdjMXBDM1ppYTBnNWVzRnE4TDdqUndsYjZYZ09vVldaVHBv?oc=5", "source_name": "Market source", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) director receives 4,642 deferred stock units", "summary": "GoodRx (NASDAQ: GDRX) director Ronald E. Bruehlman was granted 4,642 deferred stock units at no cash cost. These units, representing a contingent right to one share of Class A common stock each, will vest 2% on May 31, 2026, with the remainder vesting monthly over seven months, s", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-aa5b7fe78e45.html", "source_name": "Stock Titan", "published_at": "2026-05-29T22:09:25", "published_display": "29 May 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) director grant adds 4,642 deferred stock units", "summary": "GoodRx Holdings, Inc. director Douglas Joseph Hirsch was granted 4,642 deferred stock units at a price of $0.00 per share on May 27, 2026. This grant increases his direct holdings to 247,502 shares of Class A common stock. The units have a vesting schedule where 2% vest on May 31", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-12abd72f3327.html", "source_name": "Stock Titan", "published_at": "2026-05-29T22:09:24", "published_display": "29 May 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Shifting Story For GoodRx (GDRX) Is Reshaping Analyst Views And Valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQc3VvczZQbjFzbWFiYlR4MXJWSUJsY0Q3SC1fZi0wbkRQVmRxaHM2NFVMRGdhZVBCZHFWd2ZBZjhxOUx3VVRoVUYtVFY5S1pPYUdPVmRpMS1ZUWp3U01DT0lvdUt1eVFfdjRuVFFIT1RJVm8xU3laalRGZUlIUXg4d29LaUlad181czZyN3k4cVV5QjhFcl9vWXVrTnVSbGQ1WnBZ?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx: TrumpRx Exposes Legacy Moat Breach And Zero-Sum Strategy (Downgrade) (NASDAQ:GDRX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNUzF1UzVSRlRSM1VpQlo3VHViekRLOTJWaDFXZEI3bjNUNi05QllpeE1KcWJaY01VaUZhVGpWUHEwY3RiQTgzeFlaV3VPdXh2aWMwcnVnWElQaUpGVkc0QVFVRjdVVU44WnkyS19sa2J5bjBFUGh5SmpuY01nSnlqd2pvWDdzcnUtWDVodURfZjdCRFhMZFNKdHZlWXVCQS1YQl9EckJONVlOVkw5cU5hc3lfVTA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) CAO exercises RSUs and delivers shares to cover taxes", "summary": "GoodRx Holdings, Inc.'s Chief Accounting Officer, Thomas Chan, exercised 5,575 restricted stock units, converting them into Class A common stock. To cover tax obligations related to these vestings, 2,838 shares were disposed of at $2.49 per share through a non-market, tax-withhol", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-8bdf0acb693b.html", "source_name": "Stock Titan", "published_at": "2026-05-15T21:10:03", "published_display": "15 May 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) executive exercises 44,779 RSUs, 19,726 shares for taxes", "summary": "GoodRx Holdings executive Christopher A. McGinnis exercised 44,779 restricted stock units to acquire Class A common stock and concurrently surrendered 19,726 shares to cover tax obligations. These routine transactions are related to equity compensation and not open-market sales. ", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-76881d2d802e.html", "source_name": "Stock Titan", "published_at": "2026-05-15T21:10:03", "published_display": "15 May 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Some May Be Optimistic About GoodRx Holdings' (NASDAQ:GDRX) Earnings", "summary": "Despite soft profit numbers, GoodRx Holdings' recent earnings report pleased the market due to signs of underlying promise. The company's profit was notably reduced by US$14 million due to unusual, likely one-off, items, suggesting its true earnings potential might be understated", "url": "https://www.sahmcapital.com/news/content/some-may-be-optimistic-about-goodrx-holdings-nasdaqgdrx-earnings-2026-05-14", "source_name": "Sahm", "published_at": "2026-05-15T04:39:28", "published_display": "15 May 2026 04:39", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Jim Cramer Says 'Pull The Trigger' On Chevron", "summary": "Jim Cramer recommends buying Chevron (CVX) due to its strong cash flow, 3.8% yield, and the fact that its stock was significantly higher the last time oil prices were at current levels. He also commented on GoodRx, Vertiv, and Sterling Infrastructure, advising caution for the lat", "url": "https://www.sahmcapital.com/news/content/why-jim-cramer-says-pull-the-trigger-on-chevron-2026-05-13", "source_name": "Sahm", "published_at": "2026-05-13T21:09:04", "published_display": "13 May 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX) awards 54,494 RSUs to Chief Accounting Officer Thomas Chan", "summary": "GoodRx Holdings, Inc. has granted 54,494 restricted stock units (RSUs) to its Chief Accounting Officer, Thomas Chan. These RSUs represent a contingent right to receive one share of Class A common stock each. The award will vest in 1/12 increments quarterly, beginning on August 15", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-4-good-rx-holdings-inc-insider-trading-activity-dd3c780fba9d.html", "source_name": "Stock Titan", "published_at": "2026-05-12T23:09:03", "published_display": "12 May 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GDRX (NASDAQ: GDRX) Form 144 \u2014 43,100-share proposed sale", "summary": "Morgan Stanley Smith Barney LLC Executive Financial Services has filed a Form 144 to report a proposed sale of 43,100 shares of Common stock for GoodRx Holdings, Inc. (NASDAQ: GDRX). The shares are comprised of two restricted stock lots dated June 3, 2025 (25,852 shares) and July", "url": "https://www.stocktitan.net/sec-filings/GDRX/144-good-rx-holdings-inc-sec-filing-e475815d10b2.html", "source_name": "Stock Titan", "published_at": "2026-05-12T14:40:57", "published_display": "12 May 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx vs. Hims & Hers Health: Stagnation vs. Growth in Revenue", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNdjFVYXBnbmItZi1qeE5zNFR2aVNuZ21pTDltUmFLVDd1Snc2NG9BMzlNWmxaM3RERV9oRlBoeHN6cllRNkFZeDBual9vTE93cE4tZHBubHFPR0RsVEpnckYzQXJ5T1AtNlltNHZKYTRhSV9idGdLMEpiNW5HdkZ3QmhFQ2IxbXBQU1ZCN0tvSHZSUUpxNXZuSGMzY3NzZnFPcnVmbXNhanJadU0?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings (GDRX) Thin Q1 Profit Margins Test Bullish Earnings Growth Narratives", "summary": "GoodRx Holdings (GDRX) reported Q1 2026 revenue of US$194.0 million and basic EPS of US$0.00, with trailing net profit margins at 2.6%. Despite analyst forecasts for 26.2% earnings growth, current thin margins, a one-off US$18.7 million loss, and a high P/E ratio compared to peer", "url": "https://www.sahmcapital.com/news/content/goodrx-holdings-gdrx-thin-q1-profit-margins-test-bullish-earnings-growth-narratives-2026-05-08", "source_name": "Sahm", "published_at": "2026-05-09T02:09:27", "published_display": "09 May 2026 02:09", "sentiment": "negative", "sentiment_pct": 35, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Reports First Quarter 2026 Results", "summary": "GoodRx Holdings, Inc. announced its financial results for the first quarter of 2026, reporting revenue of $194.0 million and net income of $1.2 million. While overall revenue decreased by 4% year-over-year, its Pharma Direct revenue saw an 82% increase, and subscription revenue g", "url": "https://www.businesswire.com/news/home/20260506399684/en/GoodRx-Reports-First-Quarter-2026-Results", "source_name": "Business Wire", "published_at": "2026-05-08T02:09:48", "published_display": "08 May 2026 02:09", "sentiment": "positive", "sentiment_pct": 69, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) Q1 2026 shifts from Rx volume to Pharma Direct growth", "summary": "GoodRx Holdings, Inc. (NASDAQ: GDRX) reported a shift in revenue composition for Q1 2026, with overall revenue slightly decreasing to $194.0 million from $203.0 million year-over-year. The core prescription transactions business saw a 24% decline, attributed to fewer Monthly Acti", "url": "https://www.stocktitan.net/sec-filings/GDRX/10-q-good-rx-holdings-inc-quarterly-earnings-report-e3ba8aa22a00.html", "source_name": "Stock Titan", "published_at": "2026-05-07T06:10:33", "published_display": "07 May 2026 06:10", "sentiment": "negative", "sentiment_pct": 41, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) grows Pharma Direct and lifts 2026 outlook", "summary": "GoodRx reported Q1 2026 revenue of $194.0 million, a 4% decrease year-over-year, largely due to a 24% decline in prescription transactions revenue. However, Pharma Direct revenue surged 82% to $52.2 million, and subscription revenue increased 16% to $24.4 million, reflecting a st", "url": "https://www.stocktitan.net/sec-filings/GDRX/8-k-good-rx-holdings-inc-reports-material-event-3079d56a2c62.html", "source_name": "Stock Titan", "published_at": "2026-05-07T03:10:10", "published_display": "07 May 2026 03:10", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQZkJoajlsNnhqUHZhRWx3ZUw2RnU3dWNEeFl2WlVjb2dZM21RRmFTRm15TUdCVkxGUXJ4Xy1wSW1NSE1qVzJoUGY0S0lBVXcwTGFnVE1BbHk4OEFmX2xUUzdfMXBySW8zblZJcEo0djJSUVVmZi1tbWxfb1NmVjh3S1JrNnBINmt3WEsybDFqeXd5NFkxYTJj?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why GoodRx (GDRX) Stock Is Trading Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQaGd5T3I5R01sdUtMeEpZOTRFX2RfbERHSjlHcFB4OURjQzdNakZiRFJ5NGlONmZEaGQ0WGNhdjVBNVpfTElmWEF0STFJTmZLbFhTWlExaXRpOTlBTjJQREg0WFRkWEpFWGd0Y0psSXpjRDk1dDg1QkFFSEs3dHE2aFpXN3JVUkZzOERZWGtTNHRqY3pFcGM4TTlR?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (NASDAQ: GDRX) CAO Thomas Chan reports stock, options and RSUs", "summary": "GoodRx Holdings, Inc. Chief Accounting Officer Thomas Chan has filed an initial ownership report (Form 3) detailing his holdings in the company. The filing indicates direct ownership of 1,000 Class A common shares, multiple stock options with varying exercise prices and expiratio", "url": "https://www.stocktitan.net/sec-filings/GDRX/form-3-good-rx-holdings-inc-initial-statement-of-beneficial-ownership-cf5f7f2a3511.html", "source_name": "Stock Titan", "published_at": "2026-05-01T21:39:08", "published_display": "01 May 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Executive pay, auditor change headline GoodRx (NASDAQ: GDRX) 2026 vote", "summary": "GoodRx Holdings, Inc. (NASDAQ: GDRX) is holding its 2026 virtual Annual Meeting of Stockholders on June 16, 2026. Key agenda items include the election of three Class III directors, the ratification of KPMG LLP as the independent registered public accounting firm, and an advisory", "url": "https://www.stocktitan.net/sec-filings/GDRX/def-14a-good-rx-holdings-inc-definitive-proxy-statement-d267c45a2b03.html", "source_name": "Stock Titan", "published_at": "2026-04-30T11:09:22", "published_display": "30 Apr 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Going On With GoodRx Stock Thursday?", "summary": "GoodRx Holdings, Inc. (NASDAQ: GDRX) shares are gaining premarket following the announcement of expanding access to Eli Lilly and Company\u2019s (NYSE: LLY) new oral GLP-1 medication, Foundayo, starting at $149 per month. The company is also expanding access to Zepbound, available sta", "url": "https://www.sahmcapital.com/news/content/whats-going-on-with-goodrx-stock-thursday-2026-04-09", "source_name": "Sahm", "published_at": "2026-04-28T02:09:09", "published_display": "28 Apr 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Technology Stocks Q4 Recap: Benchmarking GoodRx (NASDAQ:GDRX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQdE5Udjk5ajVJc1hXS3RLLXAyc3otNnc5am9paGZHbllYSkVwSDVyN2wwQnI4Z3BKWWEzQmQtMXNuVVFEbzd6UlBlOU9nQmFhU2RRWEVzYWU2LW5IdUVhUXQ5SDRqbnI1azVHVU45cGdoN2pOMFFnOFpEWXVwMGhFRW1TX2ppU0RtVUo2VTRhYlNvR1hrcFVNQk93Z3FqOU1TNjFWODNvZDM3dw?oc=5", "source_name": "Market source", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A higher-dose Wegovy now costs $399 a month through GoodRx", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOekZTSF9SLVJYVE1mT29WZzR1Nnk5dHZNY3hnY01SOWE0cEt6djF5dTVmVkVic1RsS0h3Y2xmS0hPWi1UUVRsZ0FqMTlKMkhOUzAzek5ZSjJ4VWJtZ3pMdFk1UGVaYlY4TjlwckIwOTBMaTFNb0daWkdJNFFZdmwydENCcjNtcTBYQjFFd0I4SHRnV29qeVBHalQ5YmhySDJzMnFDZmpGWVFib1RIOGtxemFhdldYaWgxME5N?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why GoodRx (GDRX) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQZ0h0bUREaXM4a1VnLTJ3M3dSV01SSkx5ZmZkczhIWER5cXBRTnd4MmppMUN3VVVxSl9rQ25RSDB2a3lhVkZveUR6eFFqeFV6ak1saEVPLVJmNXBMb05sR1B4QzNRVE9ZUGVycjhpcThpQklyMk9KdWdLbjZnN3pEdlRDd25xaFVsZlFiN3k0V21sa3lOZDVv?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx brings Lilly's new weight-loss pill to pharmacies nationwide", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNTnVoNTJTb1BLSE9KbE81ZEpINFQxOGszU013aHJiX0FZTk9oc0JxNjh1WjdhZHFSeGJGd2ZOTmxIWnpXVDFQYXFoZWxYcmdwUnFQZ0pfaFpsMVlXRXlPSnF5VG9aS19fNW9qTElIWDByaUdOOTZmcGl6QzllQ054QWRTUmx5Y3kwUGU1SG03S1ZCcGliRmUzc1d6M05JU3lKbUdBRGtxY0hKX21KSzVxWWgtOWVHak84dHE0?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is GoodRx (GDRX) Using Employer Direct to Redefine Its Role in Workplace Drug Benefits?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-01T08:00:00+00:00", "published_display": "01 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx\u2019s (NASDAQ:GDRX) Q4 CY2025 Sales Top Estimates But Stock Drops 11.8%", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE1PNUQ0QWVJVWRDX0FtcnJrSW5mV3VtdmlYWHczMEFXRDNBTW9PYVRXZ2RUU2J3SVBudmVWaDR2N19GYkRMUXlJZ0FZa1pwejh1cG1iSDJiV2dFZGF5WTFqMGtRMHdlRkFFdjV2aDBXOXRPdUpoSU5BcWlnb0JFZzg?oc=5", "source_name": "Market source", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx (GDRX): Buy, Sell, or Hold Post Q3 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE0yNnZCWGlzSXpSbkx1eDdLSi1jUzZULXYxWVdkY2dOUFVDUkREMUFOLVNMbjhwWnBfYmFpT1hPaFlPYmtJRjhSc3pCTndRV0JKcGJBNWVvT2d4b3EyejJVNEp5azhWWEpWZnBUNlNFTUFJeExTQTQ1NXhvOA?oc=5", "source_name": "Market source", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings, Inc.'s (NASDAQ:GDRX) biggest owners are retail investors who got richer after stock soared 7.5% last week", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-07T08:00:00+00:00", "published_display": "07 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-19T08:00:00+00:00", "published_display": "19 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx Offers FDA-Approved Wegovy Pill at $149 Monthly Cash Price Across US Pharmacies", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOYlpadFhLcGZyUzZtSTVFNVRMVDBFdGM4ZXdmQVVtbThkMGtMdEFmWkJCVDRNMXhMUVdWYlNuemlKb3ZRbUR1VHhJc0lhMW9SYVV1X1hwcTV5X0pWR2ZsZl9ubkxxMkwxMllsVDhQSmtBVmJfOFdYNzhuSUxTdHVsRk1TdU9RTmZiMFZKMEVGQlM1ejZuc1B2cUVRRXZCaE9zXzZHQy13?oc=5", "source_name": "Pharmaceutical Commerce", "published_at": "2026-01-05T08:00:00+00:00", "published_display": "05 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How GoodRx, Texas A&M, and 2 other brands are setting examples for U.S.-based companies", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOQm1IbUYtbGJHQWh6MnZZX0N5Mm5pcFEtV1F2cFhpNjZGNnBTT1VxUm5XdHpkV3drNVp5ZlRyTk44RERERzd3MjQ1bV9XaWxtVEJmTlNtOXhzcTF0akF0UktycnpYMkRRbUVMamo2VGNRSl9kdV96d2wxV0txbmRVbGhhbF8yeENxbnJobUMycUEwYWdfY3Z6Mkx2RW1VaDFna3BvUkJKMUp1Rzg?oc=5", "source_name": "Fast Company", "published_at": "2025-12-02T08:00:00+00:00", "published_display": "02 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Don't See Light At End Of GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Tunnel And Push Stock Down 33%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-01T07:00:00+00:00", "published_display": "01 Nov 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Does GoodRx Make Money?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQNWt1aW1iQWZMNkJHbEdmNlNjVjZLemszeTNvdlM2M2ptRlpJdXVxcjQ4VEJHYmRtNFhQYU42MEJpR0IxZXFnVmJZczZYaGMzX2xleGxCMTVqcDJubWpQUUdNVS1PeG5CZVl1OGd4UEVwNmhRMmtveFNGckNwWVZOaC1HMkVpZw?oc=5", "source_name": "The Motley Fool", "published_at": "2025-10-18T07:00:00+00:00", "published_display": "18 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GoodRx stock climbs on potential TrumpRx partnership, expanded Kroger tie-up", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPWU1yb3R6ZXJzT1AzblhRaEhZcWJhZ2VSVFNVMmFsM1VzMDVJQ0xBZ0hrc0RfWWV6REI3ZkdjQ1Y3bkNEVU1reVNub0JyWHNEMTZ1RXRIT2Z1ek5CMXdqSlFIaGxZZ2k4MzNwd0hlX19jekNKNVNrMlpmVkVpREl4aWxVVFlEdlN6OWlSSFlLdG00RFJvM3J6MzB2LVB6bGlsT1lKMHFIczdFM2RvVnI1RUhucFVOWmc?oc=5", "source_name": "Fierce Healthcare", "published_at": "2025-10-03T07:00:00+00:00", "published_display": "03 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 104, "total_relevant": 57, "sentiment_summary": {"positive": 9, "negative": 3, "neutral": 45, "score": 52, "total": 57, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 15.95, "count": 29}, {"event": "earnings", "label": "Earnings", "weight": 9.9, "count": 18}, {"event": "liquidity", "label": "Balance sheet", "weight": 2.2, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 2.0, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 9, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 2.95, "latest_week": "2026-07-10", "one_week_move": -3.3, "four_week_move": 11.3, "twelve_week_move": 30.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.259216, "market_dynamics_buy_signal": false, "relative_strength": -18.113387, "fair_value_gap": -41.6, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 45.7085, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.3% over one week, +11.3% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 60, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 20}, {"label": "Market source", "count": 14}, {"label": "simplywall.st", "count": 5}, {"label": "Sahm", "count": 5}, {"label": "Business Wire", "count": 2}, {"label": "The Motley Fool", "count": 2}, {"label": "StockStory", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 57}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 29}, {"label": "Earnings", "count": 18}, {"label": "Balance sheet", "count": 4}, {"label": "Analyst action", "count": 3}, {"label": "Deals and strategy", "count": 2}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "57", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-3.3% over one week, +11.3% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's"}], "updated_at": "2026-07-16T08:08:04.934948+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}